Previous report that activated the PI3K/AKT/Nrf2 pathway and PPARα is responsible for the improvement of NAFLD, enlightening us to assess the changes of FFA-induced and GPS-induced protein level. This evidence concerns the gene NFE2L2 and metabolic dysfunction-associated steatotic liver disease.